Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
BeOne Medicines
BeOne Medicines
AVM Biotechnology Inc
New York Medical College
BeOne Medicines
AstraZeneca
Vironexis Biotherapeutics Inc.
AstraZeneca
M.D. Anderson Cancer Center
Galapagos NV
City of Hope Medical Center
University of Chicago
Medical College of Wisconsin
BeOne Medicines
City of Hope Medical Center
OHSU Knight Cancer Institute
AstraZeneca
Eli Lilly and Company
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute